Clinical Trial Update: The Role of Glutamine for Preventing Oxaliplatin-Induced Peripheral Neuropathy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update investigating whether glutamine can prevent oxaliplatin-induced peripheral neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Neuropathy

Drugs mentioned

• Glutamine (glutamine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Ankara Education and Research Hospital | Conditions: Peripheral Neuropathy | Phase 3 | Status: UNKNOWN